Stockreport

SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox

SIGA Technologies Inc.  (SIGA) 
US:NASDAQ Investor Relations: investor.siga.com/investor-relations
PDF Trials are currently underway in the United States, United Kingdom and Democratic Republic of CongoPending positive results from clinical trials, SIGA plans to file with [Read more]